Equities

Paranovus Entertainment Technology Ltd

Paranovus Entertainment Technology Ltd

Actions
Consumer Staples Food Producers
  • Price (USD)1.12
  • Today's Change0.06 / 5.66%
  • Shares traded379.00
  • 1 Year change-68.41%
  • Beta0.1814
Data delayed at least 15 minutes, as of May 06 2024 17:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Paranovus Entertainment Technology Ltd, formerly Happiness Development Group Ltd, is a company mainly engaged in the production of nutritional products. The Company's main businesses are the research and development, manufacturing and sales of nutritional products made from traditional Chinese medicine and animal extracts. The Company's main products include spore powder, cordyceps mycelium products, donkey-hide gelatin solution products, vitamins and dietary supplement products, American ginseng products and other nutrition products. The Company also engages in e-commerce and auto sales through the platforms Happy Buy and Taochejun.

  • Revenue in USD (TTM)51.46m
  • Net income in USD-42.62m
  • Incorporated1970
  • Employees80.00
  • Location
    Paranovus Entertainment Technology LtdNo. 11Dongjiao East Road, Shuangxi, ShunchangNANPING 353001ChinaCHN
  • Phone+86 5 997828808
  • Websitehttp://www.happ.org.cn/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Azitra Inc686.00k-12.64m7.67m10.00--1.11--11.18-2.99-2.990.07130.24080.1117--4.8868,600.00-183.73---266.83-------1,644.87-----45.860.0138--141.55--6.02------
Cyclerion Therapeutics Inc0.00-12.59m7.70m1.00--0.6225-----5.22-2.290.004.560.00----0.00-80.08-72.70-115.85-86.96-------2,565.62----0.00---100.00--30.98------
CV Sciences Inc16.00m3.10m7.83m42.002.332.672.350.48940.02060.02060.1040.0181.461.4626.74381,047.6028.28-43.42247.47-77.7544.2751.8119.38-45.680.373313.680.0805---1.24-19.80133.96-20.87----
Virios Therapeutics Inc0.00-5.30m7.90m4.00---------0.283-0.2830.00--------------------------------------56.76------
Cadrenal Therapeutics Inc-100.00bn-100.00bn8.00m3.00------------------------------------------------------------
Longeveron Inc709.00k-22.21m8.06m23.00--3.96--11.37-10.18-10.180.32620.42450.0359--4.3130,826.09-108.45-63.15-139.35-75.6831.1733.70-3,020.17-441.02----0.00---41.98-19.78-17.92--26.80--
NuCana PLC (ADR)0.00-34.71m8.20m25.00--0.4387-----412.56-412.560.008.840.00----0.00-64.21-41.01-102.19-48.07-----------77.430.0259------13.71---21.70--
Paranovus Entertainment Technology Ltd51.46m-42.62m8.22m80.00--0.7696--0.1597-7.16-7.499.891.461.1859.614.15643,209.90-91.12-23.19-119.36-27.214.9223.09-77.15-24.253.97-2,465.220.00--9.689.80-45.84---21.93--
Cannabis Bioscience Internatnl Hlgs Inc56.94m6.94m8.31m389.000.00150.00020.90030.14590.53280.53284.294.920.591762.811.45146,384.307.83--11.73--31.96--13.24--0.685650.750.0631--12.79--177.84------
Inhibikase Therapeutics Inc260.50k-19.03m8.36m8.00--0.7269--32.07-3.62-3.620.04891.770.0132--13.0632,562.50-96.49-66.49-117.79-85.55-----7,304.76-1,139.14----0.00--111.03-42.21-5.40------
Notable Labs Ltd310.00k-11.26m8.48m16.00--0.5609--27.35-3.08-3.080.09391.680.0126----19,375.00-45.79-52.02-56.70-62.0936.4560.19-3,633.55-3,636.93----0.0221---52.89-11.9365.13---50.69--
Plus Therapeutics Inc (USA)4.91m-13.32m8.59m20.00------1.75-4.51-4.511.57-0.30330.2787----245,650.00-75.54-59.18-210.10-133.04-----271.04-470.45----1.51--2,093.30-5.8934.32--3.77--
National Graphite Corp0.00-1.97m8.64m0.00---------0.0221-0.02210.00-0.01930.00-------11,014.44-212.13---6,295.18---------------------1,432.70------
Biofrontera Inc34.07m-20.13m8.75m85.00--0.5446--0.2569-15.19-15.1924.303.160.86461.935.42400,858.80-51.08---101.07--48.80---59.08--0.6727-2.710.4489--18.82---3,045.47------
Data as of May 06 2024. Currency figures normalised to Paranovus Entertainment Technology Ltd's reporting currency: US Dollar USD

Institutional shareholders

0.33%Per cent of shares held by top holders
HolderShares% Held
Renaissance Technologies LLCas of 31 Dec 202319.29k0.29%
GVC Gaesco Gesti�n SGIIC SAas of 31 Dec 20232.00k0.03%
UBS Securities LLCas of 31 Dec 2023842.000.01%
Tower Research Capital LLCas of 31 Dec 20230.000.00%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.